Evidence map›Paper›PMID 25077038›Full record

ArticleJournal of molecular biomarkers & diagnosis2013

Methylated Bone Morphogenetic Protein 3 (BMP3) Gene: Evaluation of Tumor Suppressor Function and Biomarker Potential in Biliary Cancer.

John B Kisiel, Jia Li, Hongzhi Zou, Abdul M Oseini, Benjamin B Strauss, Kadra H Gulaid, Catherine D Moser, Ileana Aderca, David A Ahlquist, Lewis R Roberts and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of molecular biomarkers & diagnosis, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
0.9field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it, 19 citations in OpenAlex.

  1. Biomarkers for the Diagnosis of Cholangiocarcinoma: A Systematic Review.The American journal of tropical medicine and hygiene · 2018
    Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. BMP3 Affects Cortical and Trabecular Long Bone Development in Mice.International journal of molecular sciences · 2022
    Article
  7. Article
  8. Article
  9. Article
  10. 1,25-Dihydroxyvitamin DOncoTargets and therapy · 2019
    Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

John B KisielDivision of Gastroenterology and Hepatology, Mayo Clinic, Rochester Minnesota, USA.
Jia LiDivision of Gastroenterology and Hepatology, Mayo Clinic, Rochester Minnesota, USA.
Hongzhi ZouDivision of Gastroenterology and Hepatology, Mayo Clinic, Rochester Minnesota, USA.
Abdul M OseiniDivision of Gastroenterology and Hepatology, Mayo Clinic, Rochester Minnesota, USA.
Benjamin B StraussDivision of Gastroenterology and Hepatology, Mayo Clinic, Rochester Minnesota, USA.
Kadra H GulaidDivision of Gastroenterology and Hepatology, Mayo Clinic, Rochester Minnesota, USA.
Catherine D MoserDivision of Gastroenterology and Hepatology, Mayo Clinic, Rochester Minnesota, USA.
Ileana AdercaDivision of Gastroenterology and Hepatology, Mayo Clinic, Rochester Minnesota, USA.
David A AhlquistDivision of Gastroenterology and Hepatology, Mayo Clinic, Rochester Minnesota, USA.
Lewis R RobertsDivision of Gastroenterology and Hepatology, Mayo Clinic, Rochester Minnesota, USA.
Abdirashid M ShireDivision of Gastroenterology and Hepatology, Mayo Clinic, Rochester Minnesota, USA.
WinnMed · US

Funding

Women's Cancer ProgramP30CA015083 · NCI · MAYO CLINIC ROCHESTER · PI Felicity Enders · 1985 to 2026
$151.3M
PILOT AND FEASIBILTY PROGRAMP30DK084567 · NIDDK · MAYO CLINIC ROCHESTER · PI GREGORY J. GORES · 2009 to 2026
$22.2M
Paul Calabresi Program in Clinical/Translational Research at Mayo ClinicK12CA090628 · NCI · MAYO CLINIC ROCHESTER · PI WEROHA, SARAVUT · 2001 to 2025
$19.7M
Mayo Clinic Center for Translational Science ActivitiesKL2TR000136 · NCATS · MAYO CLINIC ROCHESTER · PI KHOSLA, SUNDEEP · 2012 to 2015
$6.6M
Regulation of the Tumor Microenvironment in Hepatocellular CarcinomaR01CA165076 · NCI · MAYO CLINIC ROCHESTER · PI FERNANDEZ-ZAPICO, MARTIN ERNESTO, ROBERTS, LEWIS R · 2012 to 2016
$2.0M
Molecular Pathogenesis of Hepatocellular CarcinomaR01CA100882 · NCI · MAYO CLINIC ROCHESTER · PI ROBERTS, LEWIS R · 2004 to 2008
$1.8M
Dysregulation of the Tumor Microenvironment in Hepatocellular CarcinomaR21CA128633 · NCI · MAYO CLINIC ROCHESTER · PI ROBERTS, LEWIS R · 2009 to 2010
$366k
Molecular Pathogenesis of Hepatocellular CarcinomaR56CA100882 · NCI · MAYO CLINIC ROCHESTER · PI ROBERTS, LEWIS R · 2009 to 2009
$352k
NCATS NIH HHS KL2 TR000136NCI NIH HHS K12 CA090628NCI NIH HHS P30 CA015083NCI NIH HHS R01 CA100882NCI NIH HHS R01 CA165076NCI NIH HHS R21 CA128633NCI NIH HHS R56 CA100882NIDDK NIH HHS P30 DK084567
6 · The paper itself

Abstract

backgroundAlthough cholangiocarcinoma (CC) is an uncommon and highly lethal malignancy, early detection enables the application of potentially curative therapies and improves survival. Consequently, tools to improve the early diagnosis of CC are urgently needed. During a screen for genes epigenetically suppressed by methylation in CC that might serve as methylation markers for CC, we found that the

methodsWe aimed to quantitatively assess

resultsIn primary CC tumor tissue specimens significantly more methylated

conclusionThese findings strongly support a tumor suppressor role for

Indexed as

Biological markersCholangiocarcinomaEarly detection of cancerGallbladder neoplasms

Identifiers

PMID25077038
PMCPMC4112127
OpenAlexW2125364943

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.